Vaccine Success Rate

Pfizer/BioNTech Vaccine

The Pfizer/BioNTech vaccine has proven to be 95% effective against COVID-19. With over 43,000 participants tested, there were no severe side effects to the vaccine (only 3.8% of participants experienced fatigue and 2% of participants experienced headaches). Of the tens of thousands of people tested, only one participant contracted a severe COVID-19 case. Trials included participants of different ages, races, and ethnicities, and this vaccine has been issued an EUA, or emergency use authorization, by the FDA.

Moderna Vaccine

The Moderna vaccine has shown to be 94.1% effective against COVID-19 after conducting a study with 30,000 participants. In this same study, zero participants who had received the vaccine contracted a severe case, demonstrating that it's 100% effective against severe cases of COVID-19. Trials included participants of different ages, races, and ethnicities, and this vaccine has been issued an EUA, or emergency use authorization, by the FDA.